Dr. Rutter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8303 Dodge Street
Omaha, NE 68114
Education & Training
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2014 - 2018
- University of Tennessee Health Science Center College of MedicineClass of 2014
Certifications & Licensure
- IA State Medical License 2020 - 2026
- NE State Medical License 2020 - 2026
- CT State Medical License 2017 - 2021
- MD State Medical License 2018 - 2021
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 64 citationsCECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.Meiling Zhang, Zongzhi Z Liu, Keisuke Aoshima, Wesley L Cai, Hongyin Sun
Science Translational Medicine. 2022-02-02 - 21 citationsProceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)Chintamani D. Atreya, Simone A. Glynn, Michael P. Busch, Steve Kleinman, Edward A. Snyder
Transfusion. 2019-09-01 - 8 citationsPathogen Reduction: The State of the Science in 2019Eric A. Gehrie, Sara Rutter, Edward L. Snyder
Hematology/oncology Clinics of North America. 2019-10-01
Press Mentions
- Proceedings of the Food and Drug Administration Public Workshop on Pathogen Reduction Technologies for Blood Safety 2018May 29th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: